The IPO Buzz
IPO Calendar
Last Week's IPO Traffic
Pricings
2015 Pricings
Last 100 IPOs
Last 12 Months
IPOs by Managers
By Industry
Secondary Offerings
IPO Pipeline
SCOOP Ratings
IPOs Recently Filed
IPOs by Managers
By Industry
Secondary Offerings
Archives
SCOOP Track Record From 2000 to Present
IPO Traffic by Week
IPO Index
Zosano Pharma 
General Information
Business: We are a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver our proprietary formulations of existing drugs through the skin for the treatment of a variety of indications. Our microneedle patch system offers rapid onset, consistent drug delivery, improved ease of use and room-temperature stability, which we believe often are unavailable using oral formulations or injections. Our microneedle patch system has the potential to deliver numerous medications for a wide variety of indications in commercially attractive markets. By focusing our development efforts on the delivery of established molecules with known safety and efficacy and premium pricing, we plan to reduce our clinical and regulatory risk and development costs and accelerate our time to commercialization.
Industry: PHARMACEUTICAL PREPARATIONS
Employees: 29 Founded: 2012
Contact Information
Address: 34790 Ardentech Court, Fremont, CA 94555, US
Phone: 510-745-1200
Web Address: www.zosanopharma.com
View Prospectus: Zosano Pharma
Financial Information
Market Cap: $ 127.6 mil
Revenues: $ 3.0 mil (last 12 months)
Net Income: $ -11.8 mil (last 12 months)
IPO Profile
Symbol: ZSAN
Shares (millions): 4.5
Price Range: $11.00 - $11.00
Est.$ Volume $ 49.5 mil
Manager / Joint Managers Ladenburg Thalmann/ Roth Capital Partners
Co Managers -
Expected to Trade 1/27/2015
Status Priced
SCOOP RATING Available only to Subscribers
RATING CHANGE Available only to Subscribers


 
© 2024 IPOSCOOP.com All rights reserved.